Sumito Saeki

Ariake, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Patient-derived orthotopic xenograft models recapitulate the peritoneal dissemination of pancreatic cancer and delineate its transcriptional and regulatory programs.

Patient-derived orthotopic xenograft models recapitulate the peritoneal dissemination of pancreatic cancer and delineate its transcriptional and regulatory programs.

Journal: Journal of experimental & clinical cancer research : CR

Published: October 18, 2025

Axillary adipose tissue-derived lymphatic endothelial cells exhibit distinct transcriptomic signatures reflecting lymphatic invasion status in breast cancer.

Axillary adipose tissue-derived lymphatic endothelial cells exhibit distinct transcriptomic signatures reflecting lymphatic invasion status in breast cancer.

Journal: Breast cancer research : BCR

Published: December 17, 2024

Characterizing heterogeneous cis-regulatory elements in gene regulatory programs associated with breast cancer.

Characterizing heterogeneous cis-regulatory elements in gene regulatory programs associated with breast cancer.

Journal: Genome medicine

Published: November 13, 2024

Serial single-cell RNA sequencing unveils drug resistance and metastatic traits in stage IV breast cancer.

Serial single-cell RNA sequencing unveils drug resistance and metastatic traits in stage IV breast cancer.

Journal: NPJ precision oncology

Published: January 16, 2024

Identification of lineage-specific epigenetic regulators FOXA1 and GRHL2 through chromatin accessibility profiling in breast cancer cell lines.

Identification of lineage-specific epigenetic regulators FOXA1 and GRHL2 through chromatin accessibility profiling in breast cancer cell lines.

Journal: Cancer gene therapy

Published: November 09, 2023

Correction: Factors associated with financial toxicity in patients with breast cancer in Japan: a comparison of patient and physician perspectives.

Correction: Factors associated with financial toxicity in patients with breast cancer in Japan: a comparison of patient and physician perspectives.

Journal: Breast cancer (Tokyo, Japan)

Published: July 03, 2023

Factors associated with financial toxicity in patients with breast cancer in Japan: a comparison of patient and physician perspectives.

Factors associated with financial toxicity in patients with breast cancer in Japan: a comparison of patient and physician perspectives.

Journal: Breast cancer (Tokyo, Japan)

Published: April 20, 2023

Correction: Chromatin profile-based identification of a novel ER-positive breast cancer subgroup with reduced ER-responsive element accessibility.

Correction: Chromatin profile-based identification of a novel ER-positive breast cancer subgroup with reduced ER-responsive element accessibility.

Journal: British journal of cancer

Published: March 14, 2023

Transcriptomic intratumor heterogeneity of breast cancer patient-derived organoids may reflect the unique biological features of the tumor of origin.

Transcriptomic intratumor heterogeneity of breast cancer patient-derived organoids may reflect the unique biological features of the tumor of origin.

Journal: Breast cancer research : BCR

Published: October 23, 2022

Chromatin profile-based identification of a novel ER-positive breast cancer subgroup with reduced ER-responsive element accessibility.

Chromatin profile-based identification of a novel ER-positive breast cancer subgroup with reduced ER-responsive element accessibility.

Journal: British journal of cancer

Published: August 04, 2022

GRHL2 motif is associated with intratumor heterogeneity of cis-regulatory elements in luminal breast cancer.

GRHL2 motif is associated with intratumor heterogeneity of cis-regulatory elements in luminal breast cancer.

Journal: NPJ breast cancer

Published: January 05, 2022

Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: a retrospective single-center study.

Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: a retrospective single-center study.

Journal: BMC cancer

Published: February 15, 2021

Showing 1-12 of 12

Last Updated: 09/26/2026